Olaparib With Ceralasertib in Recurrent Osteosarcoma
Conditions: Osteosarcoma; Osteosarcoma Recurrent Interventions: Drug: Olaparib; Drug: Ceralasertib Sponsors: Dana-Farber Cancer Institute; Osteosarcoma Institute; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials